Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiovascular tolerance to tianeptine].

C Lasnier1, C Marey, G Lapeyre

  • 1I.R.I.S., Courvevoie.

Presse Medicale (Paris, France : 1983)
|November 14, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Broadening of the Divertor Heat Flux Profile in High Confinement Tokamak Fusion Plasmas with Edge Pedestals Limited by Turbulence in DIII-D.

Physical review letters·2024
Same author

Measurements of multiple heat flux components at the divertor target by using surface eroding thermocouples (invited).

The Review of scientific instruments·2022
Same author

[Severe intraocular inflammation after surgery for unilateral posterior lenticonus, resolving on topical steroids].

Journal francais d'ophtalmologie·2021
Same author

Idiopathic choroidal neovascularization in a young boy.

Journal francais d'ophtalmologie·2021
Same author

[Cogan's syndrome].

Journal francais d'ophtalmologie·2021
Same author

Formation of a High Pressure Staircase Pedestal with Suppressed Edge Localized Modes in the DIII-D Tokamak.

Physical review letters·2019

Tianeptine demonstrates a favorable cardiovascular safety profile in depressed patients, showing no significant impact on heart rate, blood pressure, or cardiac function. This antidepressant is well-tolerated, even in vulnerable populations.

Area of Science:

  • Pharmacology
  • Cardiology
  • Psychiatry

Background:

  • Cardiovascular safety is a critical concern for antidepressant medications.
  • Tianeptine is an atypical antidepressant with a distinct pharmacological profile.
  • Understanding its cardiovascular effects is essential for clinical use.

Purpose of the Study:

  • To evaluate the cardiovascular effects of tianeptine in healthy volunteers and depressed patients.
  • To compare tianeptine's cardiovascular safety with amitriptyline.
  • To assess long-term cardiovascular tolerability in large patient populations.

Main Methods:

  • Placebo-controlled trial in healthy volunteers.
  • Analysis of heart rate, blood pressure, and electrocardiogram data from five studies in depressed patients.

Related Experiment Videos

  • Open-label, long-term trials (up to one year) in over 3,300 patients.

    • Main Results:

    • Tianeptine did not alter heart rate, blood pressure, cardiac conduction, or ventricular function.
    • The drug was well-tolerated in depressed patients, including elderly, cardiovascularly compromised, and alcoholic individuals.
    • Fewer instances of orthostatic hypotension were noted compared to other antidepressants.
    • Tianeptine overdosage did not result in fatal cardiovascular complications.

    Conclusions:

    • Tianeptine exhibits a robust cardiovascular safety profile.
    • It is well-tolerated in diverse patient groups, including those with pre-existing conditions.
    • Its safety in overdose situations regarding cardiovascular events is also favorable.